You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has signed an exclusive distribution agreement for Finland. This means that it has full coverage in all Nordic countries. To add to the growing list of markets where exclusive distribution agreements are in place, Vigmed now adds Finland to their network of distributors for their pateAlready a subscriber…
The Danish biotechnology company has announced a drug developement collaboration with the global pharma giant. Saniona, previously known under the name Aniona, focuses on small molecule drug discovery within the ion channel field. The collaboration with Pfizer involves research on pharmaceuticalAlready a subscriber Login You have read all your free articles,…
AstraZeneca has entered an agreement with Grünenthal for the global rights to Zomig (zolmitriptan) outside Japan. Zomig is indicated for the acute treatment of migraines and cluster headaches, an area of medicine outside AstraZeneca’s strategic focus. Grünenthal will pay AstraZeneca $200 Already a subscriber Login You have read all your free…
Beactica Therapeutics and Oscotec, a Korean drug development company, have announced a new research development and licensing agreement. The two companies will initially jointly collaborate concerning research and early preclinical development of novel anticancer drug candidates arising out of BeAlready a subscriber Login You have read all your free articles,…
